SCHEMBL6616637

SCHEMBL6616637

c1cc2c3cc4c(cc3ncc2c2cc3c(cc12)OCO3)OCO4

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.51
MCL1 Q07820 1/20 0.51
BAK1 Q16611 1/20 0.51
ALDH1A1 P00352 9/20 0.46
SMN1; SMN2 Q16637 7/20 0.46
MAPT P10636 7/20 0.46
HPGD P15428 7/20 0.46
LMNA P02545 6/20 0.46
KDM4E B2RXH2 6/20 0.46
MAPK1 P28482 5/20 0.46
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
ACHE P22303 4/20 0.46
HTT P42858 4/20 0.46
TP53 P04637 4/20 0.46
BCHE P06276 3/20 0.46
CYP3A4 P08684 3/20 0.46
ALOX15 P16050 3/20 0.46
ALOX12 P18054 3/20 0.46
HSD17B10 Q99714 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1132076 0.88 TDP1 (0.50) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2
SCHEMBL6616039 0.86 TDP1 (0.51) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2
SCHEMBL16125304 0.72 ACHE (0.54) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2
SCHEMBL30878399 0.72 ACHE (0.54) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2
SCHEMBL30425829 0.72 ACHE (0.54) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2
Trisphaeridine SCHEMBL29746387 0.71 KDM4E (0.53) ALDH1A1SMN1; SMN2MAPTLMNAKDM4E
SCHEMBL17430669 0.70 TDP1 (0.42) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2
SCHEMBL11765501 0.69 KMT2A (0.49) BCL2L1MCL1BAK1ALDH1A1MAPT
SCHEMBL13017793 0.68 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2MAPTHPGDLMNA
SCHEMBL13170174 0.68 BCL2L1 (1.00) BCL2L1MCL1BAK1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042294-B1 HETEROCYCLIC CYTOTOXIC AGENTS UNIV RUTGERS (US) 2004-08-11 EP claimed
US-6486167-B1 Heterocyclic cytotoxic agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2002-11-26 US claimed
US-6140328-A FOR TREATING TUMOR RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2000-10-31 US claimed